Tomonori Nakazato

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Ejection Fraction

Chronic Lymphocytic Leukemia

Top Venues

Annals of hematology

Medical oncology (Northwood, London, England)

Internal medicine journal

Annals of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shuhei Kurosawa, Takako Yokota, Yusuke Takada, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report. Annals of hematology 103 (5) (2024)
Shuhei Kurosawa, Takako Yokota, Yusuke Takada, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report. Annals of hematology (2024)
Shuhei Kurosawa, Takako Yokota, Yusuke Takada, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report. Annals of hematology 103 (5) (2024)
Shuhei Kurosawa, Takako Yokota, Yusuke Takada, So Okubo, Moe Masuda, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Effective treatment of pleural effusion in chronic lymphocytic leukemia with acalabrutinib: a case report. Annals of hematology 103 (5) (2024)
So Okubo, Kohei Shinmura, Saori Kadota, Misa Nakayasu, Shuhei Kurosawa, Hitomi Nakayama, Aki Sakurai, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Evaluation of the cachexia index using a bioelectrical impedance analysis in elderly patients with non-Hodgkin's lymphoma: A single-center prospective study. Annals of hematology (2023)
Kohei Shinmura, So Okubo, Saori Kadota, Hitomi Nakayama, Aki Sakurai, Shuhei Kurosawa, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma. Annals of hematology (2022)
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors. Annals of medicine 54 (1) (2022)
Tomonori Nakazato, Masao Hagihara, Naohi Sahara, Yotaro Tamai, Ryuji Ishii, Shigehisa Tamaki, Atsushi Wake, Kenji Tajika, Rika Sakai, Takeshi Kobayashi, Jian Hua, Morihiro Inoue, Yoshinobu Aisa, Shin Fujisawa, Koji Miyazaki, Seiji Irie, Eri Tanaka, Masaaki Higashihara
Phase II clinical trial of personalized VCD-VTD sequential therapy using the Vulnerable Elders Survey-13 (VES-13) for transplant-ineligible patients with newly diagnosed multiple myeloma. Annals of hematology 100 (11) (2021)
Masahiro Akimoto, Aki Sakurai, Yuriko Nishiyama-Fujita, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine. Annals of hematology 100 (4) (2021)
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Takahiro Kamiya, Kota Mizuno, Chisako Ito, Shinji Ogura, Aki Sakurai, Tomohiko Tanigawa, Masahiro Akimoto, Yoshinobu Aisa
The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine. Hematological oncology 38 (4) (2020)
Kyoko Masuda, Tomonori Nakazato, Yuriko Nishiyama-Fujita, Chisako Ito, Shinji Ogura, Kota Mizuno, Takahiro Kamiya, Yoshinobu Aisa, Takehiko Mori
Successful treatment with ponatinib for central nervous system relapse of Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia. Internal medicine journal 49 (10) (2020)
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Chisako Ito, Shinji Ogura, Kota Mizuno, Takahiro Kamiya, Yoshinobu Aisa, Takehiko Mori
Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy. Internal medicine journal 49 (9) (2020)
Kota Mizuno, Tomonori Nakazato, Chisako Ito, Yuriko Fujita, Shinji Ogura, Takahiro Kamiya, Aki Sakurai, Yoshinobu Aisa, Takehiko Mori
The prognostic value of geriatric nutritional risk index in patients with follicular lymphoma. Annals of hematology 98 (7) (2019)
Takahiro Kamiya, Tomonori Nakazato
The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes treated with azacitidine. Medical oncology (Northwood, London, England) 36 (3) (2019)
Shinji Ogura, Shoichiro Yonei, Tomohiko Tanigawa, Masahiro Akimoto, Aki Sakurai, Yuriko Fujita, Chisako Ito, Yoshinobu Aisa, Tomonori Nakazato
Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes. Annals of hematology 99 (1) (2019)
Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Kei-Ji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Yuta Kimura, Yoshinobu Aisa, Eisaku Iwanaga, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Norio Komatsu, Tatsuya Kawaguchi
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors. Medical oncology (Northwood, London, England) 35 (7) (2018)